Marijuana compound treats schizophrenia with few side effects

Clinical trial
29 May 2012
Other news

A compound found in marijuana can treat schizophrenia as effectively as antipsychotic medications, with far fewer side effects, according to a preliminary clinical trial. Unlike the main ingredient in marijuana, THC, which can produce psychotic reactions and may worsen schizophrenia, cannabidiol (CBD) has antipsychotic effects, according to previous research in both animals and humans.

Wednesday, May 30, 2012
Time Magazine (US)